Long-term effects of biologic therapies on peripheral blood eosinophils in patients with psoriasis: a 3-year single-center study

Long-term effects of biologic therapies on peripheral blood eosinophils in patients with psoriasis: a 3-year single-center study

Background: Biologic therapies (BTs), etanercept, infliximab, adalimumab, and ustekinumab, are generally well-tolerated and safe agents in psoriasis management. Objectives: To determine the overall effect of BTs on peripheral blood eosinophil count (PBEc) and percentage (PBEp), peripheral blood baso...

Full description

Bibliographic Details
Main Authors: Neslihan Akdogan, Sibel Dogan, Nilgun Atakan
Format: Article
Language:English
Published: Taylor & Francis Group 2020-10-01
Series:Journal of Dermatological Treatment
Subjects:
psoriasis
eosinophil
biologics
Online Access:http://dx.doi.org/10.1080/09546634.2019.1605139

Similar Items

Similar Items